Skip to main content
Clinical Trials/CTRI/2019/04/018786
CTRI/2019/04/018786
Not yet recruiting
Phase 4

Comparative study of efficacy, safety and cost effectiveness of topical combination therapy with clindamycin 1% - benzoyl peroxide 2.5% versus adapalene 0.1% - benzoyl peroxide 2.5% in cases of mild to moderate facial acne vulgaris: A prospective, randomized, open label, parallel study

Government medical college Nagpur0 sites0 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Health Condition 1: L700- Acne vulgaris
Sponsor
Government medical college Nagpur
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\) Subjects of either gender
  • 2\) Subjects of 12 to 35 years of age with mild to moderate (comedones, papules and few pustules) facial acne vulgaris having more than or equal to 2 and less than equal to 30 lesions(inflammatory and/or non inflammatory) lesions

Exclusion Criteria

  • 1\)Patients already on anti\-acne medication in last one month
  • 2\) Patients having nodulocystic lesions, acne conglobata, acne fulminans, secondary acne
  • 3\) Patients unwilling to give written informed consent
  • 4\) Patients with known hypersensitivity to benzoyl peroxide, clindamycin or adapalene
  • 5\) Pregnant or lactating women

Outcomes

Primary Outcomes

Not specified

Similar Trials